Benoît Déprez

6.7k total citations · 2 hit papers
134 papers, 4.1k citations indexed

About

Benoît Déprez is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Benoît Déprez has authored 134 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 50 papers in Organic Chemistry and 18 papers in Infectious Diseases. Recurrent topics in Benoît Déprez's work include Chemical Synthesis and Analysis (30 papers), Cancer therapeutics and mechanisms (15 papers) and Tuberculosis Research and Epidemiology (14 papers). Benoît Déprez is often cited by papers focused on Chemical Synthesis and Analysis (30 papers), Cancer therapeutics and mechanisms (15 papers) and Tuberculosis Research and Epidemiology (14 papers). Benoît Déprez collaborates with scholars based in France, United States and Belgium. Benoît Déprez's co-authors include Rebecca Deprez‐Poulain, Nicolas Willand, Marion Flipo, Julie Charton, André Tartar, Terence Beghyn, Bart Staels, Florence Leroux, Alain R. Baulard and Guillaume Laconde and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Benoît Déprez

129 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

2015 538 citations Benoît Déprez, Bart Staels et al. profile →
The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity

2015 343 citations Evie P. M. Broeders, Emmani B. M. Nascimento et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Benoît Déprez

Since Specialization

Citations

This map shows the geographic impact of Benoît Déprez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Déprez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Déprez more than expected).

Fields of papers citing papers by Benoît Déprez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Déprez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Déprez. The network helps show where Benoît Déprez may publish in the future.

Co-authorship network of co-authors of Benoît Déprez

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Déprez. A scholar is included among the top collaborators of Benoît Déprez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Déprez. Benoît Déprez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of New Nanomolar Selective IRAP Inhibitors 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Ronan Gealageas, François‐Xavier Mauvais, (unknown), (unknown), (unknown), (unknown), Nathalie Azaroual, (unknown), (unknown), (unknown), Cyril Couturier, Florence Leroux, Peter Van Endert, Benoît Déprez, Rebecca Deprez‐Poulain	0
2	Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors 2024 ·Electrophoresis ·(unknown), Christophe Furman, Julie Charton, Benoît Déprez, (unknown)	0
3	N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease 2024 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Valérie Landry, Lowiese Desmarets, (unknown), François‐Xavier Cantrelle, Danai Moschidi, Adrien Herlédan, (unknown), (unknown), (unknown), (unknown), (unknown), Jean Dubuisson, Sandrine Belouzard, Xavier Hanoulle, Florence Leroux, Benoît Déprez, Julie Charton	1
4	Identification of new correctors for traffic-defective ABCB4 variants by a high-content screening approach 2024 ·Communications Biology ·(unknown), Julie Dumont, Virginie Vauthier, Julie Charton, (unknown), (unknown), (unknown), (unknown), (unknown), Martine Lapalus, Emmanuel Gonzalès, Emmanuel Jacquemin, Florent Di Meo, Benoît Déprez, Florence Leroux, Thomas Falguières	1
5	High-Throughput Quantitative Screening of Glucose-Stimulated Insulin Secretion and Insulin Content Using Automated MALDI-TOF Mass Spectrometry 2023 ·Cells ·(unknown), Egon Heuson, Adrien Herlédan, Frédérik Oger, (unknown), Mickaël Chevalier, (unknown), (unknown), Philippe Froguel, Benoît Déprez, Sébastien Paul, Jean‐Sébastien Annicotte	3
6	Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification 2023 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Catherine Piveteau, Florence Leroux, (unknown), Stéphanie Slupek, Rudy Antoine, (unknown), François‐Xavier Cantrelle, Xavier Hanoulle, Jana Korduláková, Benoît Déprez, Nicolas Willand, Alain R. Baulard, Marion Flipo	2
7	Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump 2023 ·European Journal of Medicinal Chemistry ·(unknown), Juan-Carlos Jiménez-Castellanos, (unknown), Elizabeth Pradel, (unknown), Catherine Piveteau, (unknown), (unknown), Florence Leroux, Benoît Déprez, Nicolas Willand, Ruben C. Hartkoorn, Marion Flipo	6
8	Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae 2023 ·EMBO Molecular Medicine ·(unknown), Juan-Carlos Jiménez-Castellanos, (unknown), Laurye Van Maele, (unknown), Elizabeth Pradel, (unknown), (unknown), Daphnée Soulard, Catherine Piveteau, (unknown), Julie Dumont, Florence Leroux, Benoît Déprez, Nicolas Willand, Klaas M. Pos, Achilleas S. Frangakis, Ruben C. Hartkoorn, Marion Flipo	12
9	Identification of indole-based activators of insulin degrading enzyme 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xiaoan Wen, Valérie Landry, Adrien Herlédan, Florence Leroux, Damien Bosc, Julie Charton, (unknown), (unknown), Isabelle Duplan, Catherine Piveteau, Nathalie Hennuyer, Bart Staels, Benoît Déprez, Rebecca Deprez‐Poulain	7
10	NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment 2021 ·Angewandte Chemie International Edition ·François‐Xavier Cantrelle, Emmanuelle Boll, (unknown), Danai Moschidi, Sandrine Belouzard, Valérie Landry, Florence Leroux, Frédérique Dewitte, Isabelle Landrieu, Jean Dubuisson, Benoît Déprez, Julie Charton, Xavier Hanoulle	30
11	NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment 2021 ·Angewandte Chemie ·François‐Xavier Cantrelle, Emmanuelle Boll, (unknown), Danai Moschidi, Sandrine Belouzard, Valérie Landry, Florence Leroux, Frédérique Dewitte, Isabelle Landrieu, Jean Dubuisson, Benoît Déprez, Julie Charton, Xavier Hanoulle	1
12	High-Throughput Image-Based Aggresome Quantification 2020 ·SLAS DISCOVERY ·(unknown), Ludovic Chaput, (unknown), (unknown), Catherine Piveteau, Julie Dumont, (unknown), Benoît Déprez, Florence Leroux	7
13	The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force 2019 ·Orphanet Journal of Rare Diseases ·(unknown), Noel Southall, Madhusudan Natarajan, Lilian Pek Lian Lau, Anneliene Hechtelt Jonker, Benoît Déprez, Tim Guilliams, Lawrence Hunter, Carin M. A. Rademaker, Virginie Hivert, Diego Ardigò	19
14	Drug Target Engagement Using Coupled Cellular Thermal Shift Assay—Acoustic Reverse-Phase Protein Array 2019 ·SLAS DISCOVERY ·Adrien Herlédan, (unknown), (unknown), Florence Leroux, (unknown), Catherine Piveteau, (unknown), Cyril Couturier, Benoît Déprez, Rebecca Deprez‐Poulain	9
15	Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 2017 ·Scientific Reports ·(unknown), Elisabetta Pancani, Samuel Jouny, Arnaud Machelart, Vincent Delorme, Giuseppina Salzano, Raffaella Iantomasi, Catherine Piveteau, Christophe J. Queval, Ok‐Ryul Song, Marion Flipo, Benoît Déprez, Jean‐Paul Saint‐André, J. Hureaux, Laleh Majlessi, Nicolas Willand, Alain R. Baulard, Priscille Brodin, Ruxandra Gref	67
16	The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity breakdown → 2015 ·Cell Metabolism ·Evie P. M. Broeders, Emmani B. M. Nascimento, Bas Havekes, Boudewijn Brans, Kay H. M. Roumans, Anne Tailleux, Gert Schaart, Mostafa Kouach, Julie Charton, Benoît Déprez, Nicole D. Bouvy, Felix M. Mottaghy, Bart Staels, Wouter D. van Marken Lichtenbelt, Patrick Schrauwen	343
17	Tuberculosis: The drug development pipeline at a glance 2012 ·European Journal of Medicinal Chemistry ·Baptiste Villemagne, Céline Crauste, Marion Flipo, Alain R. Baulard, Benoît Déprez, Nicolas Willand	136
18	Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery 2008 ·Chemical Biology & Drug Design ·Terence Beghyn, Rebecca Deprez‐Poulain, Nicolas Willand, Benoı̂t Folléas, Benoît Déprez	67
19	PDE5 inhibitors: An original access to novel potent arylated analogues of tadalafil 2006 ·Bioorganic & Medicinal Chemistry Letters ·Terence Beghyn, Candide Hounsou, Benoît Déprez	28
20	A library of novel hydroxamic acids targeting the metallo-protease family: Design, parallel synthesis and screening 2006 ·Bioorganic & Medicinal Chemistry ·Marion Flipo, Terence Beghyn, Julie Charton, Vincent Leroux, Benoît Déprez, Rebecca Deprez‐Poulain	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact